Amperos Health Secures $16M Series A to Scale AI-Powered Denial Management

Amperos Health closed a $16 million Series A funding round led by Bessemer Venture Partners. The company's platform uses AI to automate the denial appeals process, identifying winnable cases and generating appeal letters. This funding signals continued venture capital investment in automating the back-end of RCM, particularly as payer denial rates remain high. While not a direct policy change, it highlights the market's focus on tools that address administrative burden. Billing managers evaluating denial management vendors should add Amperos to their competitive analysis.